Navigation Links
NeurogesX to Hold Conference Call to Discuss Third Quarter 2010 Results
Date:10/28/2010

SAN MATEO, Calif., Oct. 28 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will hold a conference call on Wednesday, November 3, 2010 at 8:30 a.m. EDT (5:30 a.m. PDT) to report results for its third quarter ended September 30, 2010.

The conference call will be hosted by Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, Executive Vice President, Chief Operating Officer and Chief Financial Officer.

To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International).  To access the live web cast please visit the Investor Relations section on the corporate web site at http://www.neurogesx.com.

A replay of the conference call will be available beginning November 3, 2010 at 11:30 a.m. EDT (8:30 a.m. PDT) and ending on November 13, 2010 by dialing 1-877-870-5176 (USA) or 1-858-384-5517 (International) with Conference ID Number: 359770.  A replay of the webcast will also be available on the corporate website through December 3, 2010.

About NeurogesX, Inc.NeurogesX, Inc. (Nasdaq: NGSX) is a San Francisco Bay Area-based biopharmaceutical company focused on developing and commercializing novel pain management therapies. NeurogesX was founded on the concept that use of prescription-strength capsaicin could help manage the pain associated with neuropathic pain conditions. Since its inception, NeurogesX has leveraged its passion to help people with pain to efficiently develop this concept, resulting in the commercial launch of Qutenza® (capsaicin) 8% patch in 2010. The Company continues to apply its knowledge and expertise in the development of other novel
'/>"/>

SOURCE NeurogesX
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
3. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
4. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
5. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
6. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
7. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
8. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
9. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
10. NeurogesX to Present at JMP Securities Healthcare Focus Conference
11. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Sept. 1, 2015 Taiwan,s ... press conference in Taipei on  ... new Vaucarrin™ platform, a targeted drug delivery technology that ... This event was part of a joint press conference ... NanoTech Inc. (GNT), showcasing GNT,s latest edible gold-based food ...
(Date:9/1/2015)... 2015 The global ... of sectors, products & services and application. And the ... the increasing demand of advanced drugs for the ... the growth for bioinformatics market. The implementation of ... known as bioinformatics. Decreasing cost of DNA sequencing, ...
(Date:9/1/2015)... DUBLIN , Aug. 31, 2015 ... the addition of the "Introduction to Veterinary ... to their offering. This course ... a good introduction to those concerned with Veterinary ... experienced personnel who reqire a better understanding of ...
Breaking Medicine Technology:GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2
... Gregory Ellison, Director of Advanced Medical Center, Licensed to ... ... critical crisis,of methamphetamine use, Dr. Gregory Ellison, Director of Advanced Medical,Center, ... success rates and is performed on an out-patient (versus,in-patient) basis in ...
... Radiothon reached listeners in nine,cities across the United ... Yolanda Adams,Morning Show and nine Radio One gospel ... Jude Radiothon on Thursday, April 3,2008, benefiting St. ... the United States, the national fundraiser helped raise,awareness ...
Cached Medicine Technology:Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 2Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 3The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude 2The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude 3
(Date:9/1/2015)... ... September 01, 2015 , ... ... (NAPBS®) has announced that Edge Information Management has been granted continued ... Screening Credentialing Council (BSCC). , “Achieving and maintaining this accreditation takes ...
(Date:9/1/2015)... ... 2015 , ... With former IBMers among its founding members, Inmar has known ... than 35 years ago. A pilot program begun by the company in 2014 has ... those intent on pursuing careers in these fields. The program is now open to ...
(Date:9/1/2015)... ... September 01, 2015 , ... Royal River Natural Foods, a ... followed men and women for 19 years and found that, among those who had ... multivitamins. , The report is part of the September 2015 issue of “Natural Insights ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , the ... muscular dystrophy (FSHD), will be the beneficiary of a collection of fundraising events this ... raise awareness of the FSH Society and further FSHD research. , The ...
(Date:9/1/2015)... , ... September 01, 2015 , ... SC&H Group, a ... which includes being named a “Best of the Best” firm in the U.S., as ... named the “Best of the Best” in the U.S., selected exclusively on performance in ...
Breaking Medicine News(10 mins):Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2
... A new study by researchers at the University of British ... , The study, published in the Journal of Public ... are three times more likely than those who don,t to ... minimum of physical activity. , Doctoral student Ugo Lachapelle and ...
... YORK, March 26 California has one of ... As more people become,uninsured due to the ... of programs that helps people without prescription coverage,save ... Hispanics about,how to access necessary medications. During "Cover ...
... The Susan G. Komen for the Cure(R) Advocacy ... (D-MA) and Kay Bailey Hutchison (R-TX) to reignite the ... 21st Century Cancer ALERT ( A ccess to ... and T reatment) Act. (Logo: ...
... March 26 Methodist Hospital in Houston has ... to settle allegations that it defrauded the federal ... resolves allegations that Methodist improperly increased charges to ... from Medicare. In addition to its standard ...
... part of government strategy to tackle issue , , ... U.S. rivers were found to be tainted with traces ... study from the U.S. Environmental Protection Agency and Baylor ... and two types of antidepressants were among the seven ...
... 2009 Two University of Rhode Island scientists have revealed ... species (ROS) -- a type of stress signal. Their findings ... human cells and may help in the design of drugs ... Professor Gongqin Sun in the URI Department of Cell and ...
Cached Medicine News:Health News:Public transit users 3 times more likely to meet fitness guidelines: UBC research 2Health News:As the Number of Unemployed Grows, Pfizer Helpful Answers and SABEResPODER Join Forces to Educate Hispanics Who Lack Health Insurance About How to Access Prescription Medicines 2Health News:As the Number of Unemployed Grows, Pfizer Helpful Answers and SABEResPODER Join Forces to Educate Hispanics Who Lack Health Insurance About How to Access Prescription Medicines 3Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Senators Kennedy, Hutchison for Bipartisan Cancer Alert Act 2Health News:Houston's Methodist Hospital to Pay U.S. More Than $9 Million to Resolve Allegations of Overcharging Medicare 2Health News:Fish in U.S. Rivers Tainted With Common Medications 2Health News:URI scientists reveal mechanism that regulates cancer-causing gene 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: